BioCentury
ARTICLE | Company News

Medigene, Sinphar Pharmaceutical deal

July 16, 2012 7:00 AM UTC

Medigene granted Sinphar's SynCore Biotechnology Co. Ltd. subsidiary exclusive rights to co-develop and commercialize EndoTAG-1 in Asia, Australia and New Zealand. SynCore will fund the Asian portion...